SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Collaborative Innovation in Pharmaceutical Industry: Approaches and Requirements
4 references·0 citing·19 second hop
Collaborative Innovation in Pharmaceutical Industry: Approaches and Requirements (2014)Collaborative Innovation in Pharmaceutica…Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare (2012)Promoting drug discovery by c…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Grants4Targets – an innovative approach to translate ideas from basic research into novel drugs (2010)Grants4Targets – an innovativ…Open access chemical and clinical probes to support drug discovery (2009)Open access chemical and clin…Open Innovation: The New Imperative for Creating and Profiting from Technology (2003)Drug discovery: new models for industry–academic partnerships (2008)Open innovation networks between academia and industry: an imperative for breakthrough therapies (2009)How academic labs can approach the drug discovery process as a way to synergize with big pharma (2013)Opening the door to innovation (2014)Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making? (2018)An index to quantify an individual's scientific research output (2005)Are Patents Impeding Medical Care and Innovation? (2010)Role and reality: technology transfer at Canadian universities (2010)US academic drug discovery (2011)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Can the pharmaceutical industry reduce attrition rates? (2004)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc. (2013)Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data (2016)When more isn’t merrier: pharmaceutical alliance networks and breakthrough innovation (2019)
this work references cited by second hop

References

  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,686 cited
  • 2009Open access chemical and clinical probes to support drug discovery130 cited
  • 2010Grants4Targets – an innovative approach to translate ideas from basic research into novel drugs32 cited
  • 2012Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare22 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work